FR2676443B1 - Nouveaux derives de perhydroisoindole et leur preparation. - Google Patents

Nouveaux derives de perhydroisoindole et leur preparation.

Info

Publication number
FR2676443B1
FR2676443B1 FR9106036A FR9106036A FR2676443B1 FR 2676443 B1 FR2676443 B1 FR 2676443B1 FR 9106036 A FR9106036 A FR 9106036A FR 9106036 A FR9106036 A FR 9106036A FR 2676443 B1 FR2676443 B1 FR 2676443B1
Authority
FR
France
Prior art keywords
preparation
halogen atom
symbol
perhydroisoindole derivatives
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9106036A
Other languages
English (en)
French (fr)
Other versions
FR2676443A1 (fr
Inventor
Achard Daniel
Grisoni Serge
Hannessian Stephen
Moutonnier Claude
Peyronel Jean-Francois
Tabart Michel
Truchon Alain
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer SA filed Critical Rhone Poulenc Rorer SA
Priority to FR9106036A priority Critical patent/FR2676443B1/fr
Priority to CS932448A priority patent/CZ244893A3/cs
Priority to IL101867A priority patent/IL101867A0/xx
Priority to MX9202288A priority patent/MX9202288A/es
Priority to HU9303250A priority patent/HUT68913A/hu
Priority to EP92911071A priority patent/EP0586471B1/fr
Priority to US08/146,142 priority patent/US5508433A/en
Priority to YU51692A priority patent/YU51692A/sh
Priority to ZA923541A priority patent/ZA923541B/xx
Priority to SK1268-93A priority patent/SK126893A3/sk
Priority to DE69201058T priority patent/DE69201058T2/de
Priority to PCT/FR1992/000430 priority patent/WO1992020654A1/fr
Priority to CA002109297A priority patent/CA2109297A1/fr
Priority to EP92401330A priority patent/EP0514274A1/fr
Priority to TW081103793A priority patent/TW226991B/zh
Priority to AU18840/92A priority patent/AU1884092A/en
Priority to ES92911071T priority patent/ES2066620T3/es
Priority to FI935072A priority patent/FI935072A7/fi
Priority to JP4510463A priority patent/JPH06507628A/ja
Priority to NZ242773A priority patent/NZ242773A/xx
Priority to AT92911071T priority patent/ATE116295T1/de
Priority to DK92911071.6T priority patent/DK0586471T3/da
Priority to IE157992A priority patent/IE921579A1/en
Publication of FR2676443A1 publication Critical patent/FR2676443A1/fr
Application granted granted Critical
Publication of FR2676443B1 publication Critical patent/FR2676443B1/fr
Priority to NO933976A priority patent/NO933976L/no
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FR9106036A 1991-05-17 1991-05-17 Nouveaux derives de perhydroisoindole et leur preparation. Expired - Lifetime FR2676443B1 (fr)

Priority Applications (24)

Application Number Priority Date Filing Date Title
FR9106036A FR2676443B1 (fr) 1991-05-17 1991-05-17 Nouveaux derives de perhydroisoindole et leur preparation.
CS932448A CZ244893A3 (en) 1991-05-17 1992-05-12 Novel perhydroisoindole derivatives, and process for preparing thereof
IL101867A IL101867A0 (en) 1991-05-17 1992-05-14 Perhydroisoindole derivatives and their preparation
ES92911071T ES2066620T3 (es) 1991-05-17 1992-05-15 Nuevos derivados de perhidroisoindol y su preparacion.
EP92911071A EP0586471B1 (fr) 1991-05-17 1992-05-15 Derives de perhydroisoindole et leur preparation
US08/146,142 US5508433A (en) 1991-05-17 1992-05-15 Derivatives of perhydroisoindole and preparation thereof
YU51692A YU51692A (sh) 1991-05-17 1992-05-15 Novi derivati perhidroizoindola i njihovo dobijanje
ZA923541A ZA923541B (en) 1991-05-17 1992-05-15 New perhydroisoindole derivatives and their preparation
SK1268-93A SK126893A3 (en) 1991-05-17 1992-05-15 Derivatives of perhydroisoindole and preparation thereof
DE69201058T DE69201058T2 (de) 1991-05-17 1992-05-15 Perhydroisoindol derivate und ihre herstellung.
PCT/FR1992/000430 WO1992020654A1 (fr) 1991-05-17 1992-05-15 Nouveaux derives de perhydroisoindole et leur preparation
CA002109297A CA2109297A1 (fr) 1991-05-17 1992-05-15 Nouveaux derives de perhydroisoindole et leur preparation
MX9202288A MX9202288A (es) 1991-05-17 1992-05-15 Nuevos derivados de per hidro iso indol y procedimiento para su preparacion.
TW081103793A TW226991B (enExample) 1991-05-17 1992-05-15
AU18840/92A AU1884092A (en) 1991-05-17 1992-05-15 Novel derivatives of perhydroisoindole and preparation thereof
HU9303250A HUT68913A (en) 1991-05-17 1992-05-15 Novel derivatives of perhydroisoindole and preparation thereof
FI935072A FI935072A7 (fi) 1991-05-17 1992-05-15 Uudet perhydroisoindolit ja niiden valmistus
JP4510463A JPH06507628A (ja) 1991-05-17 1992-05-15 新規ペルヒドロイソインドール誘導体及びその製造
NZ242773A NZ242773A (en) 1991-05-17 1992-05-15 4,4-diphenylisoindole derivatives
AT92911071T ATE116295T1 (de) 1991-05-17 1992-05-15 Perhydroisoindol derivate und ihre herstellung.
DK92911071.6T DK0586471T3 (da) 1991-05-17 1992-05-15 Perhydroisoindolderivater og deres fremstilling
EP92401330A EP0514274A1 (fr) 1991-05-17 1992-05-15 Nouveaux dérivés de perhydroisoindole et leur préparation
IE157992A IE921579A1 (en) 1991-05-17 1992-07-01 New perhydroisoindole derivatives and their preparation
NO933976A NO933976L (no) 1991-05-17 1993-11-03 Nye perhydroisoindolderivater og deres fremstilling

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9106036A FR2676443B1 (fr) 1991-05-17 1991-05-17 Nouveaux derives de perhydroisoindole et leur preparation.

Publications (2)

Publication Number Publication Date
FR2676443A1 FR2676443A1 (fr) 1992-11-20
FR2676443B1 true FR2676443B1 (fr) 1993-08-06

Family

ID=9412908

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9106036A Expired - Lifetime FR2676443B1 (fr) 1991-05-17 1991-05-17 Nouveaux derives de perhydroisoindole et leur preparation.

Country Status (23)

Country Link
US (1) US5508433A (enExample)
EP (2) EP0514274A1 (enExample)
JP (1) JPH06507628A (enExample)
AT (1) ATE116295T1 (enExample)
AU (1) AU1884092A (enExample)
CA (1) CA2109297A1 (enExample)
CZ (1) CZ244893A3 (enExample)
DE (1) DE69201058T2 (enExample)
DK (1) DK0586471T3 (enExample)
ES (1) ES2066620T3 (enExample)
FI (1) FI935072A7 (enExample)
FR (1) FR2676443B1 (enExample)
HU (1) HUT68913A (enExample)
IE (1) IE921579A1 (enExample)
IL (1) IL101867A0 (enExample)
MX (1) MX9202288A (enExample)
NO (1) NO933976L (enExample)
NZ (1) NZ242773A (enExample)
SK (1) SK126893A3 (enExample)
TW (1) TW226991B (enExample)
WO (1) WO1992020654A1 (enExample)
YU (1) YU51692A (enExample)
ZA (1) ZA923541B (enExample)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2676442B1 (fr) * 1991-05-17 1993-08-06 Rhone Poulenc Rorer Sa Nouveau derives de perhydroisoindole, leur preparation et les compositions pharmaceutiques qui les contiennent.
FR2689889B1 (fr) * 1992-04-10 1994-06-10 Rhone Poulenc Rorer Sa Nouveaux derives de perhydroisoindole, et leur preparation.
US5508424A (en) * 1993-03-26 1996-04-16 Ortho Pharmaceutical Corporation 4-arylisoindole analgesics
FR2703679B1 (fr) * 1993-04-05 1995-06-23 Rhone Poulenc Rorer Sa Nouveaux derives de perhydroisoindole, leur preparation et les compositions pharmaceutiques qui les contiennent.
FR2710913B1 (fr) * 1993-10-07 1995-11-24 Rhone Poulenc Rorer Sa Nouveaux dérivés de perhydroisoindole, leur préparation et les compositions pharmaceutiques qui les contiennent.
FR2709752B1 (fr) * 1993-07-30 1995-10-06 Rhone Poulenc Rorer Sa Nouveaux dérivés de perhydroisoindole, leur préparation et les compositions pharmaceutiques qui les contiennent.
TW365603B (en) * 1993-07-30 1999-08-01 Rhone Poulenc Rorer Sa Novel perhydroisoindole derivatives, their preparation and pharmaceutical compositions which contain them
FR2728165A1 (fr) 1994-12-19 1996-06-21 Oreal Utilisation d'un antagoniste de substance p pour le traitement des rougeurs cutanees d'origine neurogene
FR2728169A1 (fr) 1994-12-19 1996-06-21 Oreal Utilisation d'un antagoniste de substance p pour le traitement des prurits et des dysesthesies oculaires ou palpebrales
FR2728166A1 (fr) 1994-12-19 1996-06-21 Oreal Composition topique contenant un antagoniste de substance p
FR2741262B1 (fr) 1995-11-20 1999-03-05 Oreal Utilisation d'un antagoniste de tnf-alpha pour le traitement des rougeurs cutanees d'origine neurogene
MXPA02004330A (es) 1999-11-03 2004-07-30 Albany Molecular Res Inc Tetrahidroisoquinolinas aril-y heteroaril-sustituidas y uso de las mismas para bloquear la recaptacion de norepinefrina, dopamina y serotonina..
US7163949B1 (en) 1999-11-03 2007-01-16 Amr Technology, Inc. 4-phenyl substituted tetrahydroisoquinolines and use thereof
BR0112350A (pt) 2000-07-11 2003-06-24 Albany Molecular Res Inc Composto, composição farmacêutica, e, método de tratar um animal afligido por um distúrbio neurológico ou psicológico
US6709651B2 (en) 2001-07-03 2004-03-23 B.M.R.A. Corporation B.V. Treatment of substance P-related disorders
CA2573271C (en) 2004-07-15 2015-10-06 Amr Technology, Inc. Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
ES2382814T3 (es) 2005-05-17 2012-06-13 Merck Sharp & Dohme Ltd. Ácido cis-4-[(4-clorofenil)sulfonil]-4-(2,5-difluorofenil)ciclohexanopropanoico para el tratamiento del cáncer
KR101589551B1 (ko) 2005-07-15 2016-02-02 알바니 몰레큘라 리써치, 인크. 아릴- 및 헤테로아릴-치환된 테트라히드로벤자제핀, 및 노르에피네프린, 도파민 및 세로토닌의 재흡수를 차단하기 위한 용도
GB0603041D0 (en) 2006-02-15 2006-03-29 Angeletti P Ist Richerche Bio Therapeutic compounds
US20110218176A1 (en) 2006-11-01 2011-09-08 Barbara Brooke Jennings-Spring Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development
CA2674436C (en) 2007-01-10 2012-07-17 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors
EP2170076B1 (en) 2007-06-27 2016-05-18 Merck Sharp & Dohme Corp. 4-carboxybenzylamino derivatives as histone deacetylase inhibitors
AR071997A1 (es) 2008-06-04 2010-07-28 Bristol Myers Squibb Co Forma cristalina de 6-((4s)-2-metil-4-(2-naftil)-1,2,3,4-tetrahidroisoquinolin-7-il)piridazin-3-amina
US9156812B2 (en) 2008-06-04 2015-10-13 Bristol-Myers Squibb Company Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
WO2010114780A1 (en) 2009-04-01 2010-10-07 Merck Sharp & Dohme Corp. Inhibitors of akt activity
MX2011011901A (es) 2009-05-12 2012-01-20 Albany Molecular Res Inc Tetrahidroisoquinolinas aril, heteroaril, y heterociclo sustituidas y uso de las mismas.
EP2429296B1 (en) 2009-05-12 2017-12-27 Albany Molecular Research, Inc. 7-([1,2,4,]triazolo[1,5,-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4- tetrahydroisoquinoline and use thereof
AU2010247735B2 (en) 2009-05-12 2015-07-16 Albany Molecular Research, Inc. Crystalline forms of (S)-7-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)- 1,2,3,4-tetrahydroisoquinoline and use thereof
JP5099731B1 (ja) 2009-10-14 2012-12-19 メルク・シャープ・アンド・ドーム・コーポレーション ｐ５３活性を増大する置換ピペリジン及びその使用
CN103068980B (zh) 2010-08-02 2017-04-05 瑟纳治疗公司 使用短干扰核酸（siNA）的RNA干扰介导的联蛋白（钙粘蛋白关联蛋白质），β1（CTNNB1）基因表达的抑制
SI2606134T1 (sl) 2010-08-17 2019-08-30 Sirna Therapeutics, Inc. RNA-INTERFERENČNO POSREDOVANO ZAVIRANJE IZRAŽANJA GENA VIRUSA HEPATITISA B (HBV) Z UPORABO KRATKE INTERFERENČNE NUKLEINSKE KISLINE (siNA)
US8883801B2 (en) 2010-08-23 2014-11-11 Merck Sharp & Dohme Corp. Substituted pyrazolo[1,5-a]pyrimidines as mTOR inhibitors
US8946216B2 (en) 2010-09-01 2015-02-03 Merck Sharp & Dohme Corp. Indazole derivatives useful as ERK inhibitors
WO2012036997A1 (en) 2010-09-16 2012-03-22 Schering Corporation Fused pyrazole derivatives as novel erk inhibitors
EP2632472B1 (en) 2010-10-29 2017-12-13 Sirna Therapeutics, Inc. Rna interference mediated inhibition of gene expression using short interfering nucleic acids (sina)
EP2654748B1 (en) 2010-12-21 2016-07-27 Merck Sharp & Dohme Corp. Indazole derivatives useful as erk inhibitors
US20140045832A1 (en) 2011-04-21 2014-02-13 Piramal Enterprises Limited Insulin-Like Growth Factor-1 Receptor Inhibitors
WO2013063214A1 (en) 2011-10-27 2013-05-02 Merck Sharp & Dohme Corp. Novel compounds that are erk inhibitors
EP3358013B1 (en) 2012-05-02 2020-06-24 Sirna Therapeutics, Inc. Short interfering nucleic acid (sina) compositions
CN105050598B (zh) 2012-09-28 2018-04-27 默沙东公司 作为erk抑制剂的新型化合物
ME02925B (me) 2012-11-28 2018-04-20 Merck Sharp & Dohme Kompozicije i postupci za liječenje kancera
JP6387013B2 (ja) 2012-12-20 2018-09-12 メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． Ｈｄｍ２阻害薬としての置換されたイミダゾピリジン類
EP2951180B1 (en) 2013-01-30 2018-05-02 Merck Sharp & Dohme Corp. 2,6,7,8 substituted purines as hdm2 inhibitors
WO2015034925A1 (en) 2013-09-03 2015-03-12 Moderna Therapeutics, Inc. Circular polynucleotides
US10975084B2 (en) 2016-10-12 2021-04-13 Merck Sharp & Dohme Corp. KDM5 inhibitors
US10947234B2 (en) 2017-11-08 2021-03-16 Merck Sharp & Dohme Corp. PRMT5 inhibitors
WO2019094312A1 (en) 2017-11-08 2019-05-16 Merck Sharp & Dohme Corp. Prmt5 inhibitors
US11993602B2 (en) 2018-08-07 2024-05-28 Merck Sharp & Dohme Llc PRMT5 inhibitors
EP3833667B1 (en) 2018-08-07 2024-03-13 Merck Sharp & Dohme LLC Prmt5 inhibitors
KR20210046009A (ko) 2018-08-07 2021-04-27 머크 샤프 앤드 돔 코포레이션 Prmt5 억제제

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4042707A (en) * 1976-02-19 1977-08-16 E. I. Du Pont De Nemours And Company 3α-Arylhydroisoindoles
AU502760B2 (en) * 1977-02-28 1979-08-09 Science Union Et Cie, Societe Francaise De Recherche Medicale Azabicycloalkanes and their preparation
EP0093805B1 (en) * 1981-02-17 1987-05-13 Warner-Lambert Company Octahydro-2-(omega-mercaptoalkanoyl)3-oxo-1h-isoindole-1-carboxylic acids and esters
US4439229A (en) * 1981-06-29 1984-03-27 Rohm And Haas Company Substituted phthalimides herbicides
JPH0278659A (ja) * 1988-09-12 1990-03-19 Shionogi & Co Ltd アザビシクロアルカン類化合物
FR2654725B1 (fr) * 1989-11-23 1992-02-14 Rhone Poulenc Sante Nouveaux derives de l'isoindolone, leur preparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
ES2066620T3 (es) 1995-03-01
FR2676443A1 (fr) 1992-11-20
ATE116295T1 (de) 1995-01-15
FI935072L (fi) 1993-11-16
CZ244893A3 (en) 1994-04-13
WO1992020654A1 (fr) 1992-11-26
IL101867A0 (en) 1992-12-30
AU1884092A (en) 1992-12-30
TW226991B (enExample) 1994-07-21
EP0586471B1 (fr) 1994-12-28
FI935072A0 (fi) 1993-11-16
IE921579A1 (en) 1992-11-18
HU9303250D0 (en) 1994-03-28
US5508433A (en) 1996-04-16
SK126893A3 (en) 1994-11-09
DE69201058D1 (de) 1995-02-09
NO933976D0 (no) 1993-11-03
CA2109297A1 (fr) 1992-11-18
FI935072A7 (fi) 1993-11-16
DK0586471T3 (da) 1995-06-06
EP0586471A1 (fr) 1994-03-16
NZ242773A (en) 1994-06-27
NO933976L (no) 1993-11-03
JPH06507628A (ja) 1994-09-01
MX9202288A (es) 1992-11-01
YU51692A (sh) 1994-06-10
HUT68913A (en) 1995-08-28
ZA923541B (en) 1993-01-27
DE69201058T2 (de) 1995-05-11
EP0514274A1 (fr) 1992-11-19

Similar Documents

Publication Publication Date Title
FR2676443B1 (fr) Nouveaux derives de perhydroisoindole et leur preparation.
FR2749304B1 (fr) Nouveaux derives du 3-(piperid-4-yl)1,2-benzisoxazole et du 3-(piperazin-4-yl)1,2-benzisoxazole, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
FR2654726B1 (fr) Nouveaux derives de l'isoindolone et leur preparation.
FI924381A0 (fi) Derivat av pyrimidinnukleosid med tumoermotverkande effekt, framstaellning och anvaendning av dessa.
DE69033935D1 (de) Bis(3,4-Dialkylbenzyliden)sorbitolacetale und diese enthaltende Zusammensetzungen
ATE192154T1 (de) Triazolopyrimidinderivate
SE8107537L (sv) Nya derivat av heterocykliska aminoalcoyler, deras framstellningssett och deras terapeutiska anvendning
FI965020A0 (fi) Uusia yhdisteitä, menetelmiä niiden valmistamiseksi ja kasvaintenvastaisia aineita
MX9806246A (es) PIPERIDINAS NOVEDOSAS DERIVADAS DE 1-/(PIPERAZIN-1-IL)ARIL-(OXI/AMINO)CARBONIL(4-ARIL-PIPERIDIN A COMO ANTAGONISTAS SELECTIVOS DEL RECEPTOR 5-HT-1D- beta-.
ES2169220T3 (es) Derivados de vitamina d3 con sustituyentes en la posicion 2.
DK0700914T3 (da) Campththecinderivater, deres fremstilling og antitumormidler
ATE111887T1 (de) Mesomorphe verbindung, sie enthaltende flüssigkristalline zusammensetzung, sie verwendende flüssigkristalline vorrichtung und anzeigeapparat.
FR2616433B1 (fr) Nouveaux derives piperazinyl alkyl piperazine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
ATE129997T1 (de) Glykosidasehemmende piperidinverbindungen.
FR2625647B1 (fr) Association herbicide synergique a base de bifenox et de sulfonamides
NO842345L (no) Heksahydropyrrolo(2,1-a)isoquinolin-derivater.
FR2601364B1 (fr) Nouveaux derives de la piperazine dione-2,6, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
RU93058289A (ru) Производные пергидроизоиндола, способы их получения
FR2611715B1 (fr) Nouveaux acetamides derives de la dihydro-2,3 phenyl-3 benzofurannone-2, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
ATE91487T1 (de) Dibenzodioxazecin- und dibenzodioxaazacycloundecin-derivate.